The results of a cytotoxicity assay on the C6 cells and of nanoparticles cellular uptake demonstrated that anti-EPHA3 functionalization could enhance GBM targeting increasing the cytotoxic effect of the drug. This evidence concerns the gene EPHA3 and glioblastoma.